» Articles » PMID: 25370745

HIF‑1 Signaling Pathway Involving INOS, COX‑2 and Caspase‑9 Mediates the Neuroprotection Provided by Erythropoietin in the Retina of Chronic Ocular Hypertension Rats

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2014 Nov 6
PMID 25370745
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to investigate the impacts of erythropoietin (EPO) on the electroretinogram b‑wave (ERG‑b), and on the mRNA and protein expression levels of hypoxia‑inducible factor‑1α (HIF‑1α), inducible nitric oxide synthase (iNOS), cyclooxygenase‑2 (COX‑2) and caspase‑9 in chronic ocular hypertension rats. Episcleral vein cauterization (EVC) was used to establish the chronic ocular hypertension rat model based on the intraocular pressure (IOP) value. ERG‑b and mRNA and protein expression levels of HIF‑1α, iNOS, COX‑2 and caspase‑9 in normal, EVC‑treated and EVC combined with EPO (EVC+EPO)‑treated rats were measured by electroretinography, RT‑PCR and western blotting, respectively. Moreover, the correlations of HIF‑1α with IOP, ERG‑b, iNOS, COX‑2 and caspase‑9 were evaluated. The mRNA and protein expression levels of HIF‑1α, iNOS, COX‑2 and caspase‑9 in EVC‑treated rats were increased significantly compared with normal rats. The peak expression levels of HIF‑1α, iNOS, COX‑2 and caspase‑9 were respectively obtained 7, 7, 7 and 14 days postoperatively. Compared with EVC‑treated rats, EPO administration weakened the mRNA and protein expression levels of HIF‑1α, iNOS, COX‑2 and caspase‑9. The mRNA expression level of HIF‑1α demonstrated a significant positive correlation with IOP and ERG‑b. HIF‑1α was positively correlated with iNOS, COX‑2 and caspase‑9 at the mRNA and protein levels. The protective effect of EPO on the retina of chronic ocular hypertension rats may be mediated by the HIF‑1 signaling pathway involving iNOS, COX‑2 and caspase‑9.

Citing Articles

Control values of intraocular pressure in different species: a review of literature.

Bakula M, Kuzman T, Rados M, Starcevic K, Jurjevic I, Mamic M Croat Med J. 2025; 65(6):518-529.

PMID: 39812101 PMC: 11748451.


The Effect of Prostaglandin F2 Analog Treatment on the Immunoexpression of Fibrosis-Associated Factors in Patients with Glaucoma Undergoing Deep Sclerotomy.

Stanic R, Vukojevic K, Filipovic N, Benzon B, Ogorevc M, Kunac N Int J Mol Sci. 2024; 25(23).

PMID: 39684329 PMC: 11640873. DOI: 10.3390/ijms252312618.


Transcriptomic analysis and validation study of key genes and the HIF‑1α/HO‑1 pathway associated with ferroptosis in neutrophilic asthma.

Lin L, Liao Z, Li Y, Pan S, Wu S, Sun Q Exp Ther Med. 2024; 28(6):433.

PMID: 39347495 PMC: 11425779. DOI: 10.3892/etm.2024.12722.


Uncovering the action mechanism of Shenqi Tiaoshen formula in the treatment of chronic obstructive pulmonary disease through network pharmacology, molecular docking, and experimental verification.

Qinjun Y, Dandan Y, Hui W, Yating G, Xinheng W, Di W J Tradit Chin Med. 2024; 44(4):770-783.

PMID: 39066538 PMC: 11337265. DOI: 10.19852/j.cnki.jtcm.20240610.002.


Melatonin and mesenchymal stem cells co-administration alleviates chronic obstructive pulmonary disease via modulation of angiogenesis at the vascular-alveolar unit.

Hanna M, Elnassag S, Mohamed D, Elbaset M, Shaker O, Khowailed E Pflugers Arch. 2024; 476(7):1155-1168.

PMID: 38740599 PMC: 11166745. DOI: 10.1007/s00424-024-02968-3.